Submitted by web@researchtop... on Tue, 01/25/2022 - 11:26
Promising Investigational Agents and Strategies for Patients with Metastatic Non-Small Cell Lung Cancer Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
Edward B Garon, MD, MS
Professor
Director, Thoracic Oncology Program
Director, Signal Transduction and Therapeutics Research Program
David Geffen School of Medicine at UCLA
Jonsson Comprehensive Cancer Center
Los Angeles, California